darpa-like spinoffs focused on local market development for biomedical science and health security. >> great idea. >> what do you think? >> i'm sorry dr. giroir is not still here. he spent years at darpa and is excited about the nexus between innovation and derisking and the kinds of problems that irene and i are dealing with all the time. i do think that the usual approaches are challenging. we did get congressional support for infectious disease rapid response we saw so many challenges with the lodge lag between emergency that we clearly have exceeded our funding capacities for, and that the resources from h 1 n 1 to ebola to zika. a very different issue is the innovation kind of investments. >> and here the funding to the security sector would bring uncapped capacities for all the public health response because the prize of the fund and our response is supposed to be 1/5 of the warhead or something, so the level of not just the technology, the knowledge, the capacities, not just the funds from the security if this dialogue goes well is uncapped. >> the other thing i would adjust very briefly is i think there's also been a lot of interesting movement bringing the matching of the pri